Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News

Welspun Corp to sell Dahej unit assets for Rs130 crore to Laxmi Organic

India Infoline News Service Oct-03-2022

As per the filing, turnover of Dahej Unit was Rs136 crore comprising of 2.09% of the Consolidated Revenues as of March 31, 2022.

Cantabil Retail India opens 7 new showrooms across India in September 2022

India Infoline News Service Oct-03-2022

Now total number of Showrooms/ Shops of the Company stands at 421.

Meghmani Finechem commissions additional capacity of 1,06,000 TPA of caustic soda; Stock jumps 1%

India Infoline News Service Oct-03-2022

The plant has been commissioned on time and within the estimated CAPEX.

Bajaj Auto reports y-o-y decline of 4% in two wheeler sales in September

India Infoline News Service Oct-03-2022

Sales of commercial vehicles of the company increased y-o-y by 13% in September

Commerce Ministry to hire professionals from private sector

India Infoline News Service Oct-03-2022

One key component of the strategy to assist India in reaching $2 trillion in exports by 2030 is the lateral recruitment of talent and knowledge from the private sector.

Zydus receives USFDA final approval for Mirabegron extended-release tablets

India Infoline News Service Oct-03-2022

The USFDA approval is to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg (USRLD: Myrbetriq).

 
Indian Equities News